These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22897066)

  • 1. An automated chemiluminescence immunoassay may detect mostly relevant IgG anticardiolipin antibodies according to revised Sydney criteria.
    Noubouossie D; Valsamis J; Corazza F; Rozen L; Debaugnies F; Demulder A
    Acta Clin Belg; 2012; 67(3):184-9. PubMed ID: 22897066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Campello E; Hoxha A; Fedrigo M; Punzi L; Simioni P
    Clin Chem Lab Med; 2015 Jun; 53(7):1083-9. PubMed ID: 25720075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L; Decavele AS; Schouwers S; Devreese K
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and clinical comparison of different immunoassay systems for the detection of antiphospholipid antibodies.
    Montaruli B; De Luna E; Erroi L; Marchese C; Mengozzi G; Napoli P; Nicolo' C; Romito A; Bertero MT; Sivera P; Migliardi M
    Int J Lab Hematol; 2016 Apr; 38(2):172-82. PubMed ID: 26847159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Van Hoecke F; Persijn L; Decavele AS; Devreese K
    Int J Lab Hematol; 2012 Dec; 34(6):630-40. PubMed ID: 22827598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome.
    Mahler M; Albesa R; Zohoury N; Bertolaccini ML; Ateka-Barrutia O; Rodriguez-Garcia JL; Norman GL; Khamashta M
    Lupus; 2016 Jul; 25(8):911-6. PubMed ID: 27252269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
    Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
    Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
    Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
    Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification.
    Ruffatti A; Olivieri S; Tonello M; Bortolati M; Bison E; Salvan E; Facchinetti M; Pengo V
    J Thromb Haemost; 2008 Oct; 6(10):1693-6. PubMed ID: 18680541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a New Panel of Automated Chemiluminescence Assays for Anticardiolipin Antibodies in the Screening for Antiphospholipid Syndrome.
    Janek D; Slavik L; Ulehlova J; Krcova V; Hlusi A; Prochazkova J
    Clin Lab; 2016 Jul; 62(7):1309-1315. PubMed ID: 28164648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of automated chemiluminescent antiphospholipid antibody assay.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2015 Nov; 136(5):1033-9. PubMed ID: 26376037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.
    Vikerfors A; Johansson AB; Gustafsson JT; Jönsen A; Leonard D; Zickert A; Nordmark G; Sturfelt G; Bengtsson A; Rönnblom L; Gunnarsson I; Elvin K; Svenungsson E
    Rheumatology (Oxford); 2013 Mar; 52(3):501-9. PubMed ID: 23159889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of new commercial enzyme-linked immunosorbent assay kits in the laboratory diagnosis of antiphospholipid syndrome in view of the revised classification criteria of the antiphospholipid syndrome.
    Devreese KM
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):651-9. PubMed ID: 17102652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A flow cytometric assay for the detection of antiphospholipid antibodies.
    Pierangeli SS; Silva LK; Harris EN
    Am Clin Lab; 1999 Jul; 18(6):18-9. PubMed ID: 10557848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antiphospholipid antibodies by automated chemiluminescence assay.
    Capozzi A; Lococo E; Grasso M; Longo A; Garofalo T; Misasi R; Sorice M
    J Immunol Methods; 2012 May; 379(1-2):48-52. PubMed ID: 22421684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of Anti-dsDNA antibody tests: Crithidia luciliae immunofluorescence test, immunoblot, enzyme-linked immunosorbent assay, chemiluminescence immunoassay].
    Yang JY; Oh EJ; Kim Y; Park YJ
    Korean J Lab Med; 2010 Dec; 30(6):675-84. PubMed ID: 21157156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of chemiluminescence immunoassay for detecting Staphylococcal enterotoxin B and C1].
    Chen LJ; Liu ZS; Dong BQ; Yang K; Li Q; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):668-9. PubMed ID: 16948922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.